Interleukin-10 Production during Septic Shock

  • M. Goldman
  • A. Marchant
Conference paper
Part of the Yearbook of Intensive Care and Emergency Medicine book series (YEARBOOK, volume 1996)


Human interleukin (IL)-10 is a protein of 160 amino acids (molecular weight: 18.5 kDa) containing two intramolecular disulfide bonds [1, 2]. It is acid-labile and appears in soluble form as a homodimer. The gene encoding IL-10, which is located on chromosome 1 both in mouse and man, contains several noncoding sequences which are thought to control its transcription and the stability of the corresponding mRNA [3]. Several cell types can produce IL-10 including CD4+ and CD8+ T cells, macrophages/monocytes, B cells, keratinocytes, mesangial cells and a variety of tumor cells [1]. In most inflammatory disorders including septic shock, cells of the monocytic lineage represent the major source of IL-10.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Moore KW, O’Garra A, de Waal Malefyt R, Vieira P, Mosmann TR (1993) Interleukin-10. Annu Rev Immunol 11: 165–190PubMedCrossRefGoogle Scholar
  2. 2.
    Windsor WT, Syto R, Tsarbopoulos A, et al (1993) Disulfide bond assignments and secondary structure analysis of human and murine interleukin-10. Biochemistry 32: 8807–8815PubMedCrossRefGoogle Scholar
  3. 3.
    Kim JM, Brannan CI, Copeland NG, Jenkins NA, Khan TA, Moore KW (1992) Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. J Immunol 148: 3618–3623PubMedGoogle Scholar
  4. 4.
    Cassatella MA, Meda L, Bonora S, Ceska M, Constantin G (1993) Interleukin-10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes: Evidence for an autocrine role of tumor necrosis factor and IL-1β in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 178: 2207–2211PubMedCrossRefGoogle Scholar
  5. 5.
    Takanaski S, Nonaka R, Xing Z, Obyrne P, Dolovich J, Jordana M (1994) Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils. J Exp Med 180: 711–715PubMedCrossRefGoogle Scholar
  6. 6.
    Bogdan C, Vodovotz Y, Nathan C (1991) Macrophage deactivation by interleukin-10. J Exp Med 174: 1549–1555PubMedCrossRefGoogle Scholar
  7. 7.
    Gazzinelli RT, Oswald IP, James SL, Sher A (1992) IL-10 inhibits parasite killing and nitrogen oxide production by IFN-γ-activated macrophages. J Immunol 148: 1792–1796PubMedGoogle Scholar
  8. 8.
    Cunha FQ, Moncada S, Liew FY (1992) Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-γ in murine macrophages. Biochem Biophys Res Commun 182: 1155–1159PubMedCrossRefGoogle Scholar
  9. 9.
    Mertz PM, Dewitt DL, Stetlerstevenson WG, Wahl LM (1994) Interleukin-10 suppression of monocyte prostaglandin H synthase-2: Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production. J Biol Chern 269: 21322–21329Google Scholar
  10. 10.
    Niiro H, Otsuka T, Kuga S, et al (1994) IL-10 inhibits prostaglandin E(2) production by lipopolysaccharide-stimulated monocytes. Int Immunol 6: 661–664PubMedCrossRefGoogle Scholar
  11. 11.
    Pradier O, Gérard C, Delvaux A, et al (1993) Interleukin-10 inhibits the induction of monocyte procoagulant activity by bacterial lipopolysaccharide. Eur J Immunol 23: 2700–2703PubMedCrossRefGoogle Scholar
  12. 12.
    Jenkins JK, Malyak M, Arend WP (1994) The effects of interleukin-10 on interleukinreceptor antagonist and interleukin-1β production in human monocytes and neutrophils. Lymphokine Cytokine Res 13: 84–89Google Scholar
  13. 13.
    Cassatella MA, Meda L, Gasperini S, Calzetti F, Bonora S (1994) Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation. J Exp Med 179: 1695–1699PubMedCrossRefGoogle Scholar
  14. 14.
    de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 174: 1209–1220CrossRefGoogle Scholar
  15. 15.
    Khün R, Löhler J, Rennick D, Rajewsky K, Müller W (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263–274CrossRefGoogle Scholar
  16. 16.
    Gérard C, Bruyns C, Marchant A, et al (1993) Interleukin-10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 177: 547–550PubMedCrossRefGoogle Scholar
  17. 17.
    Marchant A, Bruyns C, Vandenabeele P, et al (1994) Interleukin-10 controls interferon γ and tumor necrosis factor production during experimental endotoxemia. Eur J Immunol 24: 1167–1171PubMedCrossRefGoogle Scholar
  18. 18.
    Howard M, Muchamuel T, Andrade S, Menon S (1993) Interleukin 10 protects mice from lethal en do toxemia. J Exp Med 177: 1205–1208PubMedCrossRefGoogle Scholar
  19. 19.
    Bean AGD, Freiberg RA, Andrade S, Menon S, Zlotnik A (1993) Interleukin-10 protects mice against staphylococcal enterotoxin B-induced lethal shock. Infect Immunol 61: 4937–4939Google Scholar
  20. 20.
    Bermudez LE, Champsi J (1993) Infection with Mycobacterium avium induces production of interleukin-10 (IL-10), and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice. Infect Immunol 61: 3093–3097Google Scholar
  21. 21.
    Denis M, Ghadirian E (1993) IL-10 neutralization augments mouse resistance to systemic Mycobacterium avium infections. J Immunol 151: 5425–5430PubMedGoogle Scholar
  22. 22.
    Frei K, Nadal D, Pfister HW, Fontana A (1993) Listeria meningitis: Identification of a cerebrospinal fluid inhibitor of macrophage listericidal function as interleukin-10. J Exp Med 178: 1255–1261PubMedCrossRefGoogle Scholar
  23. 23.
    Durez P, Abramowicz D, Gerard C, et al (1993) In vivo induction of interleukin-10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: Differential modulation by cyclosporin A. J Exp Med 177: 551–555PubMedCrossRefGoogle Scholar
  24. 24.
    Marchant A, Vincent JL, Goldman M (1996) Interleukin-10 as a protective cytokine produced during sepsis. In: Morrison DC, Ryan JL (eds) Novel therapeutic strategies in the treatment of sepsis. Marcel Decker, New York, pp 301–311Google Scholar
  25. 25.
    Ishida H, Hastings R, Thompson-Snipes L, Howard M (1993) Modified immunological status of anti-IL-10 treated mice. Cell Immunol 148: 371–384PubMedCrossRefGoogle Scholar
  26. 26.
    van der Poll T, Marchant A, Buurman W, et al (1996) Endogenous interleukin-10 protects mice from death during septic peritonitis. J Immunol (In press)Google Scholar
  27. 27.
    Zanetti G, Heumann D, Gerain J, et al (1992) Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. J Immunol 148: 1890–1897PubMedGoogle Scholar
  28. 28.
    Florquin S, Amraoui Z, Abramowicz D, Goldman M (1994) Systemic release and protective role of IL-10 in staphylococcal enterotoxin B-induced shock in mice. J Immunol 153: 2618–2623PubMedGoogle Scholar
  29. 29.
    Marchant A, Devière J, Byl B, De Groote D, Vincent JL, Goldman M (1994) Interleukin-10 production during septicaemia. Lancet 343: 707–708PubMedCrossRefGoogle Scholar
  30. 30.
    Marchant A, Alegre ML, Hakim A, et al (1996) Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock. J Clin Immunol (In press)Google Scholar
  31. 31.
    Chernoff AE, Granowitz EV, Shapiro L, et al (1995) A randomized, controlled trial of IL-10 in humans: Inhibition of inflammatory cytokine production and immune responses. J Immunol 154: 5492–5499PubMedGoogle Scholar
  32. 32.
    Platzer C, Meisel C, Vogt K, Platzer M, Yolk HD (1995) Up-regulation of monocytic IL-10 by tumor necrosis factor-α and cAMP elevating drugs. Int Immunol 7: 517–523PubMedCrossRefGoogle Scholar
  33. 33.
    Strassmann G, Patilkoota V, Finkelman F, Fong M, Kambayashi T (1994) Evidence for the involvement of interleukin-10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E(2). J Exp Med 180: 2365–2370PubMedCrossRefGoogle Scholar
  34. 34.
    Mengozzi M, Fantuzzi G, Faggioni R, et al (1994) Chlorpromazine specifically inhibits peripheral and brain TNF production, and up-regulates IL-10 production, in mice. Immunology 82: 207–210PubMedGoogle Scholar
  35. 35.
    Tarazona R, Gonzalezgarcia A, Zamzami N, et al (1995) Chlorpromazine amplifies macrophage-dependent IL-10 production in vivo. J Immunol 154: 861–870PubMedGoogle Scholar
  36. 36.
    Ianaro A, O’Donnell CA, DiRosa M, Liew FY (1994) A nitric oxide inhibitor reduces inflammation, down-regulates inflammatory cytokines and enhances interleukin-10 production in carrageenin-induced edema in mice. Immunology 82: 370–375PubMedGoogle Scholar
  37. 37.
    Bourrie B, Bouaboula, Benoit JM, Derocq JM, Esclangon M, Casellas P (1995) Enhancement of endotoxin-induced anti-inflammatory cytokine IL10 production by the sigma ligand SR31747. 9th International Congress of Immunology, San Francisco: 897 (Abst)Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • M. Goldman
  • A. Marchant

There are no affiliations available

Personalised recommendations